Haematology

5.25 CME Credits

6 February 2020
Dubai World Trade Centre

Focusing on lab testing and interpretation of treatment of blood-related diseases, this Haematology Conference provides an opportunity for haematologists to transform patient outcomes by accelerating the impact of novel genomics, data and therapeutics in blood disorder pathology.


Key topics:

  • The haematology department and management: Quality without compromise
  • CAR-T cell therapy 
  • Molecular haematology 
  • Bone marrow Updates in flow cytometry 
  • Hematological disorders and benign hematology 
  • Coagulation considerations

Benefits of attending:

  • Debate how to effectively manage the haematology department and uphold quality without compromising on worker wellbeing
  • Review the challenges and potential for the use of CAR-T cell therapy in therapeutic treatment
  • Discover key technological breakthroughs and updates in molecular haematology to improve diagnosis and patient outcomes 
  • Identify the best practice when concerning hematological disorders and patients presenting benign blood disorders

Chair:

Dr Ziad Peerwani, Chairman, Pathology and Laboratory Medicine, Consultant, Hematopathologist, Tawam Hospital, Abu Dhabi, UAE

Activity director:

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Speaker faculty:

Dr Ahmed Alduaij, Staff Physician, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Barbara De La Salle, Director, UK National External Quality Assessment Haematology (NEQAS), Director, WHO Collaborative Centre for Quality Assurance in Haematology, Board Member, International Society of Laboratory Haematology, Watford, UK

Dr Chethan Belludi, Attending Physician, Consultant Pathologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE 

Dr Elena A Sukhacheva, Senior Manager, Global Medical and Scientific Affairs, Beckman Coulter Eurocenter, Nyon, Switzerland

Dr Hisham Abdel-Azim, Director of BMT Fellowship Program, Attending
Physician; Hematology, Oncology and Blood and Marrow Transplantation,
Investigator, Hematology-Oncology, Associate Professor of Pediatrics, Keck School of Medicine of USC, Los Angeles, California, USA

Dr Maher Sughayer, Head of Hematopathology, King Hussein Cancer Center, Amman, Jordan

Dr Mohamed Salama, Medical Director, Mayo Clinic Laboratories, Professor, Department of Laboratory Medicine and Pathology, Division of Hematopathology, Rochester, Mayo Clinic School of Medicine, Rochester, USA

Dr Rania Medhat Seliem, Consultant Hematopathologist, Head of Pathology Laboratory, Rashid Hospital, Dubai Health Authority, Dubai, UAE 

Prof Soad Khalil Al Jaouni, Hematology, Pediatric Hematology Oncology, Deputy Chair of Hematology Department, Head Division of Pediatric Hematology /Oncology, Department of Hematology, Faculty of Medicine, King Abdulaziz University, President & Founder, Saudi Society of Hematology, Jeddah, KSA 

Dr Suzanne Bakdash, Clinical Pathologist, Cleveland Clinic Ohio, Ohio, USA